Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02408718 · ClinicalTrials.gov registry record · NA

Assistive Device Training in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Portland VA Medical Center.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02408718: Completed NA study of Multiple Sclerosis, sponsored by Portland VA Medical Center.

NCT02408718 is a NA study of Multiple Sclerosis that has completed, run by Portland VA Medical Center. The registered enrollment target is 40 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02408718, a NA study of Multiple Sclerosis, has completed, sponsored by Portland VA Medical Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

Primary Outcome

Timed Up and Go test, Timed 25-Foot Walk, 2 minute timed walk), Multiple Sclerosis Walking Scale-12

Conditions Studied

Interventions

  • BEHAVIORAL Assistive Device Training

Study Locations (1)

Oregon

  • VA Portland Health Care System - Portland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-07
Est. Completion 2016-09
Phase NA
Portland VA Medical Center

15 total trials

What the finished NCT02408718 record still lists

NCT02408718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Assistive Device Training is the first listed.

NCT02408718 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT02408718 about?

NCT02408718 is a clinical study titled "Assistive Device Training in Multiple Sclerosis". The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

What is the current status of trial NCT02408718?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-07. Estimated completion is 2016-09.

What conditions does trial NCT02408718 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02408718?

The interventions under investigation include: Assistive Device Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02408718?

This trial is sponsored by Portland VA Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02408718 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02408718's enrollment target sits among peer trials

40 197th of 315 higher than 108 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02408718, the US trial registry maintained by the National Library of Medicine. NCT02408718 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.